Here you see a volatile pharma stock with fantastic earnings and only a single product. The volatile action over the summer attracts a well known shortseller who takes a heavy short and then issues a very negative "research report" that spooks a few big holders that throw their holdings on at market. Mr. short covers at a fantastic profit and probably goes long...
